Division of Infection and Immunity


IIT Seminar | Thomas Mitchell

22 July 2021, 12:00 pm–1:00 pm

'Kidney tumour derived single cell transcriptomes reveal stromal evolutionary trajectories and therapeutic targets'

Event Information

Open to



Dr Anne Pesenacker

Thomas Mitchell (Wellcome Sanger Institute) will be speaking at the UCL Institute of Immunity and Transplantation Seminar Series on Thursday 22 July.

All are welcome to attend. Please contact Fran Jackson (f.jackson@ucl.ac.uk) if you would like to join the seminar, or meet the speaker.

About the speaker

Tom Mitchell's research programme focusses on understanding how kidney tumours initiate, evolve and evade treatment. The motivation for this body of work is provided by the patients he treats as a Consultant Urologist at Addenbrooke's Hospital where he specialises in the surgical treatment of kidney cancer.

Tom is interested in deciphering how tumours evolve over many decades from normal healthy cells. Increasingly, his interest lies not only in understanding and modelling somatic mutations acquired in the developing tumour, but also how these cancer cells interact with their multi-cellular micro-environment. The over-arching aim of these approaches is to improve the clinical management of patients with cancer.

Further information